Researcher
Sofie Deschoemaeker
- Keywords (Vrije Universiteit Brussel):Applied biological sciences, biotechnology
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Adaptive immunology, Bacteriology
- Disciplines (Vrije Universiteit Brussel):General and logistic services, Social sciences
Affiliations
- Damya Laoui Lab (Research group)
Member
From1 Oct 2022 → Today - Cellular and Molecular Immunology (Research group)
Member
From1 Jan 2021 → 30 Sep 2022 - Department of Bio-engineering Sciences (Department)
Member
From1 May 2020 → Today - Department of Bio-engineering Sciences (Department)
Member
From1 May 2020 → 31 Dec 2020 - Cellular and Molecular Immunology (Research group)
Member
From15 Jan 2020 → 31 Dec 2023 - Cellular and Molecular Immunology (Research group)
Member
From15 Jan 2020 → 20 Oct 2022 - Van Ginderachter Lab (Research group)
Member
From15 Jan 2020 → 30 Sep 2022
Publications
1 - 10 of 10
- Flt3L therapy increases the abundance of Treg-promoting CCR7+ cDCs in preclinical cancer models(2023)
Authors: Emile Clappaert, Daliya Kancheva, Jan Brughmans, Ayla Debraekeleer, Pauline Bardet, Yvon Elkrim, Dagmar Lacroix, Maida Zivalj, Ahmed E. I. Hamouda, Jo Van Ginderachter, et al.
- Efficacy of CD40 agonists is mediated by distinct cDC subsets and subverted by suppressive macrophages(2022)
Authors: Aleksandar Murgaski, Máté Kiss, Helena Van Damme, Daliya Kancheva, Isaure Vanmeerbeerk, Jiri Keirsse, Eva Hadadi, Jan Brughmans, Sana M Arnouk, Ahmed E. I. Hamouda, et al.
Pages: 3785-3801 - Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions(2022)
Authors: Jesús Bravo Melgar, Sofie Deschoemaeker, Geert Raes, Anke Maes, Elke De Bruyne, Eline Menu, Karin Vanderkerken, Damya Laoui, Kim De Veirman
- IFNγ signaling response in peripheral blood monocytes: A new prognostic biomarker for breast cancer?(2020)
Authors: Sofie Deschoemaeker, Damya Laoui
Pages: 102690 - Impact of myo-inositol trispyrophosphate (ITPP) on tumour oxygenation and response to irradiation in rodent tumour models.(2018)
Authors: Le Nam Tra Tran, TT Cao-Pham, B.f. Jordan, Sofie Deschoemaeker, A Heyerick, Bernard Gallez
Pages: 1908-1916 - The mTOR and PP2A Pathways Regulate PHD2 Phosphorylation to Fine-Tune HIF1α Levels and Colorectal Cancer Cell Survival under Hypoxia(2017)
Authors: Giusy Di Conza, Sarah Trusso Cafarello, Stefan Loroch, Daniela Mennerich, Sofie Deschoemaeker, Mario Di Matteo, Manuel Ehling, Kris Gevaert, Hans Prenen, Rene Peiman Zahedi, et al.
Pages: 1699-1712 - Impeding Macrophage Entry into Hypoxic Tumor Areas by Sema3A/Nrp1 Signaling Blockade Inhibits Angiogenesis and Restores Antitumor Immunity(2013)
Authors: Andrea Casazza, Damya Laoui, Mathias Wenes, Sabrina Rizzolio, Nicklas Bassani, Marco Mambretti, Sofie Deschoemaeker, Jo Van Ginderachter, Luca Tamagnone, M. Mazzone
Pages: 695-709 - Gene-targeting of Phd2 improves tumor response to chemotherapy and prevents side-toxicity(2012)
Authors: Rodrigo Leite de Oliveira, Sofie Deschoemaeker, Anne-Theres Henze, Koen Debackere, Veronica Finisguerra, Yukiji Takeda, Carmen Roncal, Daniela Dettori, Evelyne Tack, Yannick Jönsson, et al.
Pages: 263-277 - In Vivo Identification of Adducts from the New Hypoxia-Activated Prodrug CP-506 Using DNA Adductomics
Authors: Morwena J Solivio, Alessia Stornetta, Julie Gilissen, Peter W Villalta, Sofie Deschoemaeker, Arne Heyerick, Ludwig J Dubois, Silvia Balbo
Pages: 275-282 - Selectively Targeting Tumor Hypoxia With the Hypoxia-Activated Prodrug CP-506
Authors: Alexander M A van der Wiel, Victoria Jackson-Patel, Raymon Niemans, Ala Yaromina, Emily Liu, Damiënne Marcus, Alexandra M Mowday, Natasja G Lieuwes, Rianne Biemans, Xiaojing Lin, et al.
Pages: 2372-2383